JUNE 1, 2026 AT 08:01 PM

European commission approves Amgen's (AMGN) imdylltra for the treatment of extensive-stage small cell lung cancer

Trade the TapeGet this analysis live, the moment it breaksNewsquawk's real-time dashboard delivers market-moving headlines and instant context to your desk before the rest of the market reacts.

Open Dashboard

#EUROPE#AMGEN INC#AMGN.US#EQUITIES#US SESSION#BIOTECHNOLOGY#BIOTECHNOLOGY (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#NASDAQ 100 INDEX#AMGN#US EQUITIES